# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-24-004833
Filing Date
2024-01-09
Accepted
2024-01-09 07:05:34
Documents
41
Period of Report
2024-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d90190d8k.htm iXBRL | 8-K | 26612
2 | EX-99.1 | d90190dex991.htm | EX-99.1 | 32513
7 | GRAPHIC | g90190ex99_1s10g1.jpg | GRAPHIC | 98017
8 | GRAPHIC | g90190ex99_1s11g1.jpg | GRAPHIC | 73259
9 | GRAPHIC | g90190ex99_1s12g1.jpg | GRAPHIC | 100043
10 | GRAPHIC | g90190ex99_1s13g1.jpg | GRAPHIC | 85985
11 | GRAPHIC | g90190ex99_1s14g1.jpg | GRAPHIC | 87317
12 | GRAPHIC | g90190ex99_1s15g1.jpg | GRAPHIC | 78255
13 | GRAPHIC | g90190ex99_1s16g1.jpg | GRAPHIC | 93783
14 | GRAPHIC | g90190ex99_1s17g1.jpg | GRAPHIC | 92574
15 | GRAPHIC | g90190ex99_1s18g1.jpg | GRAPHIC | 80759
16 | GRAPHIC | g90190ex99_1s19g1.jpg | GRAPHIC | 90612
17 | GRAPHIC | g90190ex99_1s1g1.jpg | GRAPHIC | 96483
18 | GRAPHIC | g90190ex99_1s20g1.jpg | GRAPHIC | 98829
19 | GRAPHIC | g90190ex99_1s21g1.jpg | GRAPHIC | 131624
20 | GRAPHIC | g90190ex99_1s22g1.jpg | GRAPHIC | 113947
21 | GRAPHIC | g90190ex99_1s23g1.jpg | GRAPHIC | 113012
22 | GRAPHIC | g90190ex99_1s24g1.jpg | GRAPHIC | 98461
23 | GRAPHIC | g90190ex99_1s25g1.jpg | GRAPHIC | 79455
24 | GRAPHIC | g90190ex99_1s26g1.jpg | GRAPHIC | 101562
25 | GRAPHIC | g90190ex99_1s27g1.jpg | GRAPHIC | 95878
26 | GRAPHIC | g90190ex99_1s2g1.jpg | GRAPHIC | 115104
27 | GRAPHIC | g90190ex99_1s3g1.jpg | GRAPHIC | 73493
28 | GRAPHIC | g90190ex99_1s4g1.jpg | GRAPHIC | 79346
29 | GRAPHIC | g90190ex99_1s5g1.jpg | GRAPHIC | 94749
30 | GRAPHIC | g90190ex99_1s6g1.jpg | GRAPHIC | 71852
31 | GRAPHIC | g90190ex99_1s7g1.jpg | GRAPHIC | 80119
32 | GRAPHIC | g90190ex99_1s8g1.jpg | GRAPHIC | 111440
33 | GRAPHIC | g90190ex99_1s9g1.jpg | GRAPHIC | 94354
| Complete submission text file | 0001193125-24-004833.txt |  | 3708799

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | mcrb-20240109.xsd | EX-101.SCH | 3235
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mcrb-20240109_def.xml | EX-101.DEF | 12931
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mcrb-20240109_lab.xml | EX-101.LAB | 21031
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mcrb-20240109_pre.xml | EX-101.PRE | 13627
35 | EXTRACTED XBRL INSTANCE DOCUMENT | d90190d8k_htm.xml | XML | 4884

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 24521708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)